Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

QNCXQNCX
2 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in QUINCE THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 16,064 shares of QNCX (QUINCE THERAPEUTICS INC), worth $1,629 as of 2026-Q1. The position was decreased (-93.0% shares).

Current Value

$1,629

Current Shares

16,064

Total Value Change

-$767,849

Total Shares Change

-213,631

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
16,064
-93.0%
$1,6290.0%$0.10
0
2025-Q4
New
229,695
-
$769,4780.0%$3.26
34

Other major holders of QNCX: Capital World Investors, Capital International Investors, Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used